COVID-19 booster update
Oct. 2022Important Notices
The FDA authorized bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines for use as a single booster dose at least two months after completing primary or booster vaccination. Anyone age 12 and older who has gotten the primary vaccination series with or without an additional booster is eligible.
Read more about COVID-19 Bivalent vaccine boosters.
Additionally, you may also visit the CDC to learn how to find a COVID-19 vaccine. Primary vaccinations and boosters for COVID-19 can be given the same day as the annual flu shot, also now available at providers and pharmacies across the Commonwealth.
For the most recent COVID-19 policy and billing updates from UPMC Health Plan, please see these resources:
- The Moderna COVID-19 Vaccine, Bivalent, is authorized for use as single booster dose in individuals 18 years old and older.
- The Pfizer-BioNTech COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 12 years old and older.
Read more about COVID-19 Bivalent vaccine boosters.
Additionally, you may also visit the CDC to learn how to find a COVID-19 vaccine. Primary vaccinations and boosters for COVID-19 can be given the same day as the annual flu shot, also now available at providers and pharmacies across the Commonwealth.
For the most recent COVID-19 policy and billing updates from UPMC Health Plan, please see these resources:
Recent Announcements
The importance of PRD forms for complex patients and staying updated on changes
Personal representative designation (PRD) forms are critical to the care process for patients and providers alike. Not only do PRDs support accurate, efficient, and compliant patient care—they also streamline administrative processes.Aug. 2025Important Notices
Important announcement: UPMC Health Plan retires MP.PA.147
This communication is in regards to UPMC Health Plan Policy MP.PA.147 – Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older. UPMC Health Plan previously communicated that the prior authorization requirement under this policy would be paused until Sept. 1, 2025. However, policy MP.PA.147 has been retired, and this policy will no longer be implemented or active.Aug. 2025Important Notices
CMS expands Medicare Advantage RADV audits to all eligible plans
On May 21, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a substantial expansion of its Risk Adjustment Data Validation (RADV) audit program for Medicare Advantage plans.Aug. 2025What's New